Trials / Unknown
UnknownNCT04452773
Clinical Trial to Evaluate the Efficacy of Food Supplement Manremyc® Against SARS- COV-2 Infection (COVID-19) in Healthcare Workers
Double-blind, Randomized, Placebo-Controlled Clinical Trial to Evaluate the Efficacy of the Manremyc® Food Supplement to Prevent SARS-CoV-2 Infection
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 315 (estimated)
- Sponsor
- Reig Jofre Group · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to assess the efficacy of Manremyc® food supplement for reduce the incidence of SARS-CoV-2 infection in a high risk population, as healthcare workers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Manremyc | Manremyc is composed by 10E5 heat-inactivated Mycobacterium s. manresensis bacilli |
| DIETARY_SUPPLEMENT | Placebo | Same excipients than active arm without bacilli. |
Timeline
- Start date
- 2020-07-14
- Primary completion
- 2020-09-01
- Completion
- 2021-12-01
- First posted
- 2020-06-30
- Last updated
- 2020-07-15
Locations
5 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT04452773. Inclusion in this directory is not an endorsement.